Relay Therapeutics Statistics
Total Valuation
RLAY has a market cap or net worth of $1.96 billion. The enterprise value is $1.41 billion.
Important Dates
The last earnings date was Thursday, February 26, 2026, after market close.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
RLAY has 178.73 million shares outstanding. The number of shares has increased by 20.10% in one year.
| Current Share Class | 178.73M |
| Shares Outstanding | 178.73M |
| Shares Change (YoY) | +20.10% |
| Shares Change (QoQ) | +0.59% |
| Owned by Insiders (%) | 2.18% |
| Owned by Institutions (%) | 57.45% |
| Float | 97.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 126.06 |
| Forward PS | n/a |
| PB Ratio | 2.81 |
| P/TBV Ratio | 3.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 92.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.61, with a Debt / Equity ratio of 0.06.
| Current Ratio | 22.61 |
| Quick Ratio | 21.68 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -41.12% and return on invested capital (ROIC) is -26.54%.
| Return on Equity (ROE) | -41.12% |
| Return on Assets (ROA) | -25.35% |
| Return on Invested Capital (ROIC) | -26.54% |
| Return on Capital Employed (ROCE) | -50.82% |
| Weighted Average Cost of Capital (WACC) | 12.97% |
| Revenue Per Employee | $81,676 |
| Profits Per Employee | -$1.47M |
| Employee Count | 188 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +194.93% in the last 52 weeks. The beta is 1.62, so RLAY's price volatility has been higher than the market average.
| Beta (5Y) | 1.62 |
| 52-Week Price Change | +194.93% |
| 50-Day Moving Average | 8.38 |
| 200-Day Moving Average | 5.65 |
| Relative Strength Index (RSI) | 74.84 |
| Average Volume (20 Days) | 2,081,053 |
Short Selling Information
The latest short interest is 19.89 million, so 11.13% of the outstanding shares have been sold short.
| Short Interest | 19.89M |
| Short Previous Month | 24.03M |
| Short % of Shares Out | 11.13% |
| Short % of Float | 20.37% |
| Short Ratio (days to cover) | 11.11 |
Income Statement
In the last 12 months, RLAY had revenue of $15.36 million and -$276.48 million in losses. Loss per share was -$1.61.
| Revenue | 15.36M |
| Gross Profit | -244.15M |
| Operating Income | -302.74M |
| Pretax Income | -276.48M |
| Net Income | -276.48M |
| EBITDA | -299.18M |
| EBIT | -302.74M |
| Loss Per Share | -$1.61 |
Full Income StatementBalance Sheet
The company has $554.52 million in cash and $32.46 million in debt, with a net cash position of $522.06 million or $2.92 per share.
| Cash & Cash Equivalents | 554.52M |
| Total Debt | 32.46M |
| Net Cash | 522.06M |
| Net Cash Per Share | $2.92 |
| Equity (Book Value) | 567.06M |
| Book Value Per Share | 3.26 |
| Working Capital | 552.70M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$235.46 million and capital expenditures -$410,000, giving a free cash flow of -$235.87 million.
| Operating Cash Flow | -235.46M |
| Capital Expenditures | -410,000 |
| Free Cash Flow | -235.87M |
| FCF Per Share | -$1.32 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,971.59% |
| Pretax Margin | -1,800.58% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
RLAY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.10% |
| Shareholder Yield | -20.10% |
| Earnings Yield | -14.28% |
| FCF Yield | -12.19% |
Analyst Forecast
The average price target for RLAY is $15.75, which is 43.44% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.75 |
| Price Target Difference | 43.44% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 70.46% |
| EPS Growth Forecast (5Y) | -10.14% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |
